• Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib
  • Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib
  • Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib
  • Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib
  • Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib
  • Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 40/g 1 g(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application & Function
  • Specification
Overview

Basic Info.

Model NO.
Dsung-Nilotinib
Product Name
Nilotinib
Name
Nilotinib Powder
Appearance
White Powder
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anticancer
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
641571-10-0
Molecular Formula
C28h22f3n7o
Einecs No.
700-544-5
Melting Point
230-242 C
Refractive Index
1.65
Density
1.36
Transport Package
Negotiable
Specification
99%
Trademark
D-Sung
Origin
Shaanxi
Production Capacity
10kg/Month

Product Description

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib
Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib
 
Product Description

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

Product Details

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

Product Name Nilotinib
CAS NO. 641571-10-0
Purity 99%
Melting point 230-242 C
Appearance and shape White powder
Nilotinib (Tasigna) is a new type of targeted cancer therapy, which belongs to the tyrosine kinase inhibitor, for the treatment of Gleevec (imatinib) resistant chronic myelogenous leukemia (CML) patients, curative effect.
Nilotinib is a molecular structure of imatinib imatinib improved and has better selectivity to BCR-ABL kinase activity, inhibition of tyrosine kinase compared with imatinib 30 times stronger inhibition on imatinib resistant mutant BCR-ABL kinase activity. It also inhibits the activity of KIT and PDGFR kinase.
Application & Function

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer NilotinibA powerful and precise second-generation tyrosine kinase inhibitor, effective in treating patients with drug-resistant or intolerant chronic myelogenous leukemia.
Nilotinib is an antitumor drug, and it is mainly used clinically to treat chronic myelogenous leukemia that is resistant to Gleevec (imatinib).

Specification

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer NilotinibPharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer NilotinibPharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer NilotinibPharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer NilotinibPharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer NilotinibPharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer NilotinibPharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP